Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Non-cash Items (2016 - 2025)

Northwest Biotherapeutics' Non-cash Items history spans 10 years, with the latest figure at -$15.2 million for Q4 2025.

  • Quarterly results put Non-cash Items at -$15.2 million for Q4 2025, down 355.56% from a year ago — trailing twelve months through Dec 2025 was $2.4 million (down 85.46% YoY), and the annual figure for FY2025 was $2.4 million, down 85.46%.
  • Non-cash Items for Q4 2025 was -$15.2 million at Northwest Biotherapeutics, down from $10.3 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $114.6 million in Q3 2022 to a low of -$143.9 million in Q4 2021.
  • The 5-year median for Non-cash Items is $2.3 million (2023), against an average of -$2.3 million.
  • The sharpest move saw Non-cash Items surged 592.87% in 2024, then tumbled 355.56% in 2025.
  • Year by year, Non-cash Items stood at -$143.9 million in 2021, then soared by 111.15% to $16.0 million in 2022, then plummeted by 87.29% to $2.0 million in 2023, then skyrocketed by 192.15% to $6.0 million in 2024, then tumbled by 355.56% to -$15.2 million in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods came in at -$15.2 million, $10.3 million, and $3.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.